Viewing Study NCT01525550

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:09 PM
Ignite Modification Date: 2026-02-20 @ 6:34 PM
Study NCT ID: NCT01525550
Status: COMPLETED
Last Update Posted: 2019-07-30
First Post: 2012-01-13
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Well-differentiated Pancreatic Neuroendocrine Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None neuroendocrine tumors View
None adenoma islet cells View
None carcinoma islet cells View
None pancreatic neoplasms View
None angiogenesis inhibitors View
None sunitinib View
None neoplasms View
None carcinoma View
None adenoma View